Physician profile
Patrick Reid
NPI 1316363666
$20,357.78
in general payments reported to CMS, 2019-2025
11 companies · $1,732 in 2025
The $1,732 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,154 · 2021: $5,408 · 2022: $6,485 · 2023: $2,060 · 2024: $519 · 2025: $1,732.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,791 · Consulting Fee: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,790.95 |
| Consulting Fee | $520.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $14,557.94 | 2021-2025 | O-Arm, Cd Horizon Spinal System, Stealthstation S8 Platform |
| Zimmer Biomet Holdings, INC. | $1,858.50 | 2019 | |
| Medical Device Business Services, INC. | $1,827.86 | 2019-2025 | Acf |
| Depuy Synthes Sales INC. | $763.33 | 2019-2025 | Trialtis, Symphony, Fibergraft Bg Morsels |
| Nuvasive, INC. | $539.64 | 2019-2022 | |
| Globus Medical, INC. | $336.22 | 2019 | |
| Medtronic USA, INC. | $293.28 | 2019 | |
| Ossdsign USA Incorporated | $105.89 | 2025 | Ossdsign Catalyst |
| Icotec Medical INC. | $41.29 | 2022 | |
| Cerapedics INC. | $24.13 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Acuity Surgical Devices, LLC | $9.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Reid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.